Eleven of the 72 people in Avelor with a saved stack hold something taken for immune support. It is
the category where the phrase on the label does the most work and the evidence does the least. It is
also the category where the phrase is wrong in a way that matters. "Immune support" implies that more
immune activity is always better. For anyone taking an immunosuppressant on purpose, more immune
activity is the opposite of what their treatment is trying to achieve. People take one on purpose
after a transplant, or for an autoimmune condition such as rheumatoid arthritis, Crohn's or
psoriasis.
The two best-evidenced things here are not products you take when a cold starts. Sleep has direct
evidence. A study using behaviourally assessed sleep rather than self-report reported that shorter
sleep predicted susceptibility to the common cold after viral exposure (PMID 26118561). A
prospective study reported an association between sleep duration and antibody acquisition after mRNA
vaccination (PMID 38149250). Vitamin D is the most studied supplement in this area and the story is
that it has weakened, not strengthened, with better analysis. An individual participant data
meta-analysis reported a protective effect against acute respiratory infection (PMID 28202713). A
second individual participant data meta-analysis examined which factors explained the heterogeneity
between trials (PMID 30675873). A 2025 systematic review and meta-analysis of stratified aggregate
data revisited the question again (PMID 39993397). Reading the sequence is more informative than
reading any one of them.
The rest of the shelf is mostly about **duration rather than prevention**, which is a smaller claim
than the packaging makes. Zinc has a Cochrane review covering both prevention and treatment
(PMID 38719213) and a systematic review focused on duration in healthy adults (PMID 32342851). A
methodological paper argues that duration outcomes in zinc lozenge trials should be analysed on the
relative scale, which changes how large the reported effect looks (PMID 28494765). Vitamin C has a
Cochrane review reporting that regular supplementation does not prevent colds in the general
population (PMID 23440782), and a later meta-analysis examining severity rather than incidence
(PMID 38082300). Echinacea has more support than its reputation suggests. There is a systematic
review and meta-analysis for prevention and treatment (PMID 31126553) and a meta-analysis in
recurrent respiratory infection (PMID 25784510). A 2024 meta-analysis examined whether it reduces
antibiotic need (PMID 38667040). Elderberry has a meta-analysis of randomised trials (PMID 30670267)
and a broader systematic review (PMID 33827515). Probiotics have a Cochrane review (PMID 36001877), a
meta-analysis in non-elderly adults (PMID 35948276), and one specifically in athletes (PMID 33481001).
Garlic is the clearest case of thin evidence: its Cochrane review found only one trial that met
inclusion (PMID 25386977).
The safety picture here is unusual because the risks are not dose-related in the ordinary way. Two of
them are about route and about the wrong person taking the right thing. Intranasal zinc has been
reported to cause loss of smell (PMID 16467707), with mechanistic work in olfactory cells supporting
the finding (PMID 27179668). Echinacea inhibits a major drug-metabolising enzyme, with a systematic
review of herb-drug interactions covering it (PMID 19719333) and a case report of an interaction with
a chemotherapy agent (PMID 22607644). One elderberry review explicitly raises the concern that it
might overstimulate the immune system (PMID 33827515). None of these is a reason for panic. All of
them are a reason to tell a clinician what you are taking.
Steps
1. **Protect sleep before buying anything.** It is the only item here with direct evidence on
susceptibility after exposure and on vaccine response (PMID 26118561, 38149250).
2. **Check whether vitamin D applies to you at all**, with whoever manages your care. The
individual participant data analyses examined who the effect appeared in, not whether everyone
benefits (PMID 28202713, 30675873, 39993397).
3. **Read the claim you are actually buying.** Most of the evidence below is about how long a cold
lasts, not whether you get one (PMID 38719213, 23440782).
4. **If you take an immunosuppressant, stop here and read the cautions first.** Immune stimulation is
not a neutral goal for you.
5. **Never put zinc in your nose** (PMID 16467707, 27179668).
Duration
Where the research supports a timeframe, the zinc and vitamin C literature is about the length of a
single illness episode, measured in days from onset (PMID 38719213, 23440782). The vitamin D
meta-analyses pooled trials that dosed over **months**, and the question they examined is infection
incidence across that period rather than the course of one infection (PMID 28202713, 30675873). The
sleep findings are observational and describe habitual sleep rather than an intervention with a start
date (PMID 26118561).
Limitations
- **Prevention and duration are different claims and are routinely blurred.** Vitamin C's Cochrane
review reports no reduction in incidence in the general population while a separate analysis
examines severity (PMID 23440782, 38082300). A label saying "supports immune function" does not
distinguish these.
- **How the effect is measured changes how large it looks.** The zinc lozenge methodology paper exists
because absolute and relative scales give different impressions of the same data (PMID 28494765).
- **Echinacea is a category, not a compound.** The reviews pool different species and different plant
parts (PMID 31126553, 25784510). Two products both labelled echinacea may not be the same
intervention.
- **Probiotic results do not transfer across strains.** The Cochrane review and the athlete-specific
review cover different organisms in different populations (PMID 36001877, 33481001).
- **Garlic has one qualifying trial.** That is stated here rather than omitted, because a Cochrane
review with one included trial is often reported as "Cochrane-reviewed" (PMID 25386977).
- **Almost none of this evidence was generated in people who are immunosuppressed.** The population
with the most to gain from getting this right is the population least represented in the trials.
Cautions
- **If you take an immunosuppressant, an immune-stimulating supplement works against your treatment.**
This includes anyone after a transplant, anyone on a biologic for an autoimmune condition, and
anyone on chemotherapy. Raise anything labelled for immune support with **the clinician who
prescribes that treatment** before starting it, not after.
- **Echinacea inhibits a major drug-metabolising enzyme, so it can change the level of other
medicines in your body** (PMID 19719333). A case report documents an interaction with a
chemotherapy agent (PMID 22607644). Raise it with **a pharmacist or your prescriber** if you take
any regular medicine.
- **Do not use zinc intranasally.** Loss of smell has been reported after intranasal zinc gel
(PMID 16467707) and mechanistic work supports the finding (PMID 27179668). This caution is about
the nasal route specifically.
- **Sustained zinc intake can deplete copper.** A micronutrient guideline and a clinical review both
address this relationship (PMID 35365361, 38367035). If you take zinc beyond a short illness,
raise it with **a clinician or dietitian**.
- **Vitamin D can be taken to the point of harm.** Toxicity and the resulting high blood calcium are
documented (PMID 32255467, 36282253, 34774245). Anyone taking it continuously should have it
managed by **the clinician who ordered it** rather than adjusted at home.
- **A fever that is high or persistent, breathlessness, or an infection that is not improving is a
reason to see a clinician**, not a reason to add another supplement. That applies with more force
if you are immunosuppressed, because the usual signs of infection can be muted.
Related canonical ingredients
Resolving to an entity and being interaction-checkable are different things. The interaction
catalogue keys on a collapsed name string rather than an entity id, so an entity can exist and still
be checked against nothing.
Resolves **and** has a catalogue key, so it can be interaction-checked:
- `avelor:sup:echinacea`
- `avelor:sup:garlic`
Resolves but has **no catalogue key**, so it displays as recognised and is checked against nothing:
- `avelor:sup:probiotics`
These do not, and no ID is invented for them here. This is the worst coverage of any guide written so
far, and it is concentrated on exactly the things people take:
- **Zinc** has no `supplement_compound` entity. It exists only as `avelor:med:zinc-acetate` and a
minimal-record medication entity.
- **Vitamin C** has no entity of either type under that name. The nearest match is
`avelor:med:6-o-palmitoylascorbic-acid`, which is a different substance.
- **Elderberry** has no supplement entity. It exists as medication-typed botanical extracts
(`avelor:med:american-elderberry-extract`, `avelor:med:european-elderberry-extract`).
- **Vitamin D** has no supplement entity, only `avelor:med:vitamin-d`. This is the second guide in
which vitamin D's absence blocks the join, after bloodsugar.
Four of the five supplements most commonly taken for this condition cannot be resolved to a
supplement entity. A user holding zinc, vitamin C, elderberry and vitamin D therefore has an
entirely unresolvable immune stack. The interaction checker cannot see any of it. The echinacea caution above
is the one genuinely actionable interaction in this guide, and echinacea is also one of only two
entities here that both resolve and carry a catalogue key.
Sources
| PMID | Title |
| --- | --- |
| 26118561 | "Behaviorally Assessed Sleep and Susceptibility to the Common Cold" |
| 38149250 | "Association between sleep duration and antibody acquisition after mRNA vaccination against SARS-CoV-2" |
| 28202713 | "Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data" |
| 30675873 | "Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis" |
| 39993397 | "Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of stratified aggregate data" |
| 38719213 | "Zinc for prevention and treatment of the common cold" |
| 32342851 | "Zinc Supplementation Reduces Common Cold Duration among Healthy Adults: A Systematic Review of Randomized Controlled Trials with Micronutrients Supplementation" |
| 28494765 | "Duration of the common cold and similar continuous outcomes should be analyzed on the relative scale: a case study of two zinc lozenge trials" |
| 23440782 | "Vitamin C for preventing and treating the common cold" |
| 38082300 | "Vitamin C reduces the severity of common colds: a meta-analysis" |
| 31126553 | "Echinacea for the prevention and treatment of upper respiratory tract infections: A systematic review and meta-analysis" |
| 25784510 | "Echinacea reduces the risk of recurrent respiratory tract infections and complications: a meta-analysis of randomized controlled trials" |
| 38667040 | "Echinacea Reduces Antibiotics by Preventing Respiratory Infections: A Meta-Analysis (ERA-PRIMA)" |
<!-- compliance-guard-allow: verbatim PubMed title, PMID 30670267, reproduced in quotation marks. The claim is the paper's and is rendered as a quotation, not as Avelor's assertion. Editing it would falsify a citation. -->
| 30670267 | "Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: A meta-analysis of randomized, controlled clinical trials" |
| 33827515 | "Elderberry for prevention and treatment of viral respiratory illnesses: a systematic review" |
| 36001877 | "Probiotics for preventing acute upper respiratory tract infections" |
| 35948276 | "Orally Ingested Probiotics, Prebiotics, and Synbiotics as Countermeasures for Respiratory Tract Infections in Nonelderly Adults: A Systematic Review and Meta-Analysis" |
| 33481001 | "Probiotic Supplementation and Respiratory Infection and Immune Function in Athletes: Systematic Review and Meta-Analysis of Randomized Controlled Trials" |
| 25386977 | "Garlic for the common cold" |
| 16467707 | "Intranasal zinc and anosmia: the zinc-induced anosmia syndrome" |
| 27179668 | "Mechanistic studies of the toxicity of zinc gluconate in the olfactory neuronal cell line Odora" |
| 19719333 | "Interactions between herbal medicines and prescribed drugs: an updated systematic review" |
| 22607644 | "Probable etoposide interaction with Echinacea" |
| 35365361 | "ESPEN micronutrient guideline" |
| 38367035 | "Role of zinc in health and disease" |
| 32255467 | "Vitamin D Toxicity" |
| 36282253 | "Hypercalcemia: A Review" |
| 34774245 | "Drug-Related Hypercalcemia" |